The generation of large numbers of functional human hepatocytes for cell-based approaches to liver disease is an important and unmet goal. Direct reprogramming of fibroblasts to hepatic lineages could offer a solution to this problem but so far has only been achieved with mouse cells. Here, we generated human induced hepatocytes (hiHeps) from fibroblasts by lentiviral expression of FOXA3, HNF1A, and HNF4A. hiHeps express hepatic gene programs, can be expanded in vitro, and display functions characteristic of mature hepatocytes, including cytochrome P450 enzyme activity and biliary drug clearance. Upon transplantation into mice with concanavalin-A-induced acute liver failure and fatal metabolic liver disease due to fumarylacetoacetate dehydr...
Abstract Background Direct reprogramming of human fibroblasts to hepatocyte-like cells was proposed ...
We previously described the generation of induced hepatocyte-like cells (iHeps) using the hepatic tr...
<div><p>Preparing targeted cells for medical applications from human induced pluripotent stem cells ...
SummaryThe generation of large numbers of functional human hepatocytes for cell-based approaches to ...
SummaryObtaining fully functional cell types is a major challenge for drug discovery and regenerativ...
SummaryRecent studies have demonstrated direct reprogramming of fibroblasts into a range of somatic ...
Recently, several researchers have reported that direct reprogramming techniques can be used to diff...
Direct reprogramming represents an easy technique to generate induced hepatocytes (iHeps) from somat...
Department of Biological SciencesGeneration of expandable patient-specific hepatocytes has great pot...
Direct reprogramming by overexpression of defined transcription factors is a promising new method of...
Abstract Background Until now, there is no effective anti-fibrotic therapy available for liver cirrh...
The limited supply and expansion capacity of primary human hepatocytes presents major challenges for...
We have designed and implemented a novel and robust approach to obtain hepatocytes from individuals ...
The conditions to induce human hepatic progenitor cells from other cell types are unclear. Here, the...
The generation of hepatic stem cells (HSCs) has a great potential for cell-based therapy in liver di...
Abstract Background Direct reprogramming of human fibroblasts to hepatocyte-like cells was proposed ...
We previously described the generation of induced hepatocyte-like cells (iHeps) using the hepatic tr...
<div><p>Preparing targeted cells for medical applications from human induced pluripotent stem cells ...
SummaryThe generation of large numbers of functional human hepatocytes for cell-based approaches to ...
SummaryObtaining fully functional cell types is a major challenge for drug discovery and regenerativ...
SummaryRecent studies have demonstrated direct reprogramming of fibroblasts into a range of somatic ...
Recently, several researchers have reported that direct reprogramming techniques can be used to diff...
Direct reprogramming represents an easy technique to generate induced hepatocytes (iHeps) from somat...
Department of Biological SciencesGeneration of expandable patient-specific hepatocytes has great pot...
Direct reprogramming by overexpression of defined transcription factors is a promising new method of...
Abstract Background Until now, there is no effective anti-fibrotic therapy available for liver cirrh...
The limited supply and expansion capacity of primary human hepatocytes presents major challenges for...
We have designed and implemented a novel and robust approach to obtain hepatocytes from individuals ...
The conditions to induce human hepatic progenitor cells from other cell types are unclear. Here, the...
The generation of hepatic stem cells (HSCs) has a great potential for cell-based therapy in liver di...
Abstract Background Direct reprogramming of human fibroblasts to hepatocyte-like cells was proposed ...
We previously described the generation of induced hepatocyte-like cells (iHeps) using the hepatic tr...
<div><p>Preparing targeted cells for medical applications from human induced pluripotent stem cells ...